Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stocks To Watch: AMRS, AMSC, CLVS, CRC, LCI, MBOT

Published 02/06/2019, 11:25 PM
Updated 07/09/2023, 06:31 AM

Wall Street took a pause and a breather and consolidated during the session on Wednesday. A lot of stocks we follow did not. They actually broke out and extended. Let’s take a look at a few of them.

Amyris, Inc. (AMRS)

AMRS, which had a big day on Tuesday on positive drug news, had a beautiful inside day on Wednesday on lower volume. Even though it was up just a penny to 5.48, technicals increased, and I still think this stock has a shot going into the 7, 8, and 9 range.

American Superconductor Corporation (AMSC)

AMSC, after a couple days of selling, popped right back, jumping 1.41, or 11%, to 13.88, on 875,877 shares traded, the biggest volume in three months, on Wednesday. In fact, intraday, it popped sharply in the morning to a high of 14.43, pulled back, and came right on again, with a terrific close. Mid-channel target is 16, upper channel target 19-20.

Clovis Oncology, Inc. (CLVS)

CLVS looks like it stuck its head out above resistance on Wednesday, running 1.06, or 4.23%, to 26.13, on 2.5 million shares, after being held back for four weeks. If the volume picks up, I think we’re still looking at 32 and 38 as targets.

California Resources Corporation (CRC)

CRC popped 48 cents, or 2.31, to 21.23, on 1.4 million shares. It’s telling me it wants to go higher. At least it looks like it. It’s above the 50-day, and above all three moving averages. I’m looking for this stock to make a move as early as Thursday to 22 3/4. If it gets through there targets are 26 and maybe 30.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lannett Company, Inc. (LCI)

LCI had a nice day on Wednesday. It broke through resistance and extended. Not much, only 12 cents, or 1.43%, to 8.52, on 1.9 million shares, but it was up another 1.17 in after hours. I like that it’s moving, and if it accelerates here, look for it to run up to the 11-12 zone.

Microbot Medical Inc. (MBOT)

MBOT has been up five days in a row with higher lows, and although it’s not accelerating there is a big OVB improvement. It was up 23 cents, or 2.29, to 10.27, on a million shares. I think it’s just a matter of time before this makes a run near 12, and a run near 13 3/4.

Stocks On The Long Side

included Amyris, (AMRS), American Superconductor Corporation (AMSC), Array BioPharma Inc. (ARRY), Codexis Inc (NASDAQ:CDXS), Clovis Oncology, Inc. (CLVS), California Resources Corporation (CRC), Enphase Energy, Inc. (ENPH), JinkoSolar Holding Company Limited (NYSE:JKS), Lannett Company, Inc. (LCI), Lattice Semiconductor Corporation (LSCC), Microbot Medical Inc. (MBOT), MacroGenics, Inc. (MGNX), Micron Technology, Inc. (NASDAQ:MU), MaxLinear, Inc. (MXL), NIO Inc. (NIO), Nektar Therapeutics (NASDAQ:NKTR), Overstock.com, Inc. (NASDAQ:OSTK), Skyline Champion Corporation (SKY), Snap Inc. (NYSE:SNAP), Energous Corporation (WATT), and Xilinx, Inc. (NASDAQ:XLNX).

Watch video here.

Latest comments

Great prediction on AMRS - dropped to half and less since a few days after
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.